Compare CMCO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMCO | LAB |
|---|---|---|
| Founded | 1875 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.4M | 402.1M |
| IPO Year | 2002 | 2008 |
| Metric | CMCO | LAB |
|---|---|---|
| Price | $13.27 | $0.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $21.00 | $1.35 |
| AVG Volume (30 Days) | 491.9K | ★ 3.4M |
| Earning Date | 05-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | N/A | ★ 0.33 |
| Revenue | ★ $936,240,000.00 | $101,937,000.00 |
| Revenue This Year | $19.73 | N/A |
| Revenue Next Year | $82.91 | $2.63 |
| P/E Ratio | ★ N/A | $2.67 |
| Revenue Growth | ★ 3.27 | N/A |
| 52 Week Low | $12.10 | $0.79 |
| 52 Week High | $24.40 | $1.72 |
| Indicator | CMCO | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 42.83 |
| Support Level | N/A | $0.90 |
| Resistance Level | $16.16 | $1.02 |
| Average True Range (ATR) | 0.83 | 0.11 |
| MACD | -0.29 | -0.03 |
| Stochastic Oscillator | 25.73 | 24.82 |
Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.